The What and Why of Managing CAR-T Cell Medical Emergencies for Non-Oncology Practitioners

CAR-T cell therapies have the potential to transform cancer treatment. Their unique toxicities require rapid recognition and specialized treatment. Collaboration between multiple disciplines is needed for the optimal management of patients undergoing CAR-T cell therapy. The purpose of this podcast is to discuss key issues that non-oncology practitioners in acute care settings will need to be familiar with to appropriately treat patients whom underwent CAR-T cell treatment and are experiencing adverse effects related to treatment.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.